Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126968211 | 12696821 | 1 | I | 20160608 | 20160830 | 20160830 | PER | JP-LUPIN PHARMACEUTICALS INC.-2016-02733 | LUPIN | SOMA N. NOTES OF MEDICAL COOPERATION STUDIED FROM INTERACTION CASE OF WARFARIN POTASSIUM AND AZITHROMYCIN SINGLE DOSE PREPARATION. DRUG INTERACTION STUDIES. 2016;39 (3):41-45. | 85.00 | YR | F | Y | 0.00000 | 20160830 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126968211 | 12696821 | 1 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | UNKNOWN | 65398 | 2 | G | ||||||||
| 126968211 | 12696821 | 2 | I | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | UNKNOWN | 65398 | |||||||||||
| 126968211 | 12696821 | 3 | I | Warfarin potassium | WARFARIN POTASSIUM | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 126968211 | 12696821 | 4 | I | Warfarin potassium | WARFARIN POTASSIUM | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 126968211 | 12696821 | 5 | I | Warfarin potassium | WARFARIN POTASSIUM | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 126968211 | 12696821 | 6 | C | Urapidil | URAPIDIL | 1 | Unknown | 15 MG | 0 | ||||||||||
| 126968211 | 12696821 | 7 | C | DIGOXIN. | DIGOXIN | 1 | Unknown | 0.125 MG | 0 | ||||||||||
| 126968211 | 12696821 | 8 | C | VERAPAMIL HYDROCHLORIDE. | VERAPAMIL HYDROCHLORIDE | 1 | Unknown | 40 MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126968211 | 12696821 | 1 | Oropharyngeal pain |
| 126968211 | 12696821 | 2 | Oropharyngeal pain |
| 126968211 | 12696821 | 3 | Cerebral artery embolism |
| 126968211 | 12696821 | 4 | Atrial fibrillation |
| 126968211 | 12696821 | 6 | Product used for unknown indication |
| 126968211 | 12696821 | 7 | Product used for unknown indication |
| 126968211 | 12696821 | 8 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126968211 | 12696821 | Drug interaction | |
| 126968211 | 12696821 | International normalised ratio increased | |
| 126968211 | 12696821 | Prothrombin time prolonged |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |